Handheld multi-modal imaging device

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top, left side perspective view of a handheld multi-modal imaging device showing our new design.

FIG. 2 is a bottom, left side perspective view thereof.

FIG. 3 is a left side view thereof.

FIG. 4 is a right side view thereof.

FIG. 5 is a top view thereof.

FIG. 6 is a bottom view thereof.

FIG. 7 is a front view thereof; and,

FIG. 8 is a back view thereof.

The broken lines of the drawings illustrate portions of the handheld multi-modal imaging device that form no part of the claimed design.

Claims

The ornamental design for a handheld multi-modal imaging device, as shown and described.

Referenced Cited
U.S. Patent Documents
D414867 October 5, 1999 Moriwaki
5971918 October 26, 1999 Zanger
6571119 May 27, 2003 Hayashi
6601997 August 5, 2003 Ngo
D480478 October 7, 2003 Leonard et al.
6678398 January 13, 2004 Wolters et al.
6889075 May 3, 2005 Marchitto et al.
D515214 February 14, 2006 Jackson, III et al.
D569378 May 20, 2008 Wanamaker
D585554 January 27, 2009 Suzuki
D605759 December 8, 2009 Cuevas
D610178 February 16, 2010 Adolfsson et al.
7846091 December 7, 2010 Fulghum
D636424 April 19, 2011 Lin
D658298 April 24, 2012 Prpa
D677793 March 12, 2013 Prpa
8620410 December 31, 2013 Frangioni
D698937 February 4, 2014 Laverack
D701606 March 25, 2014 Ohmukai
D703331 April 22, 2014 Kitayama
D703333 April 22, 2014 Saeki
D724234 March 10, 2015 Hagege
9042967 May 26, 2015 Dacosta et al.
D733595 July 7, 2015 Hoshino
D747391 January 12, 2016 Sakai
D748808 February 2, 2016 Matsumura et al.
D750260 February 23, 2016 Sauer
D753308 April 5, 2016 Marinkovich et al.
D755062 May 3, 2016 Yarden
9326666 May 3, 2016 Frangioni
9340490 May 17, 2016 Okura et al.
9451882 September 27, 2016 Nie et al.
D787684 May 23, 2017 Vezina
9743836 August 29, 2017 Tsubouchi et al.
D802777 November 14, 2017 Burachynsky et al.
D810293 February 13, 2018 Peel
D822747 July 10, 2018 Van Deusen et al.
D822748 July 10, 2018 Van Deusen et al.
D827014 August 28, 2018 Sakai
D835271 December 4, 2018 Myers et al.
D849105 May 21, 2019 Hogstedt et al.
D859498 September 10, 2019 Lin
D861176 September 24, 2019 Yoon et al.
D861764 October 1, 2019 Zhao
D862697 October 8, 2019 Kenworthy et al.
10438356 October 8, 2019 Dacosta
D865836 November 5, 2019 Puusaari
D865845 November 5, 2019 Sakai
D866764 November 12, 2019 Pukall
D868867 December 3, 2019 Jean et al.
D873890 January 28, 2020 Fidler
D884175 May 12, 2020 Aubailly
D907097 January 5, 2021 Suurmeijer et al.
D908161 January 19, 2021 Dacosta et al.
D908881 January 26, 2021 Dacosta et al.
D921736 June 8, 2021 Yin
D910105 February 9, 2021 Lin
D910182 February 9, 2021 Dacosta et al.
D913354 March 16, 2021 Marzette, Jr. et al.
D914220 March 23, 2021 Nelson et al.
D916294 April 13, 2021 Murray et al.
D919690 May 18, 2021 Suurmeijer et al.
D921899 June 8, 2021 Suarez et al.
D922469 June 15, 2021 Sjogren et al.
D924306 July 6, 2021 Melnicoff
D930845 September 14, 2021 Schmidt
D958991 July 26, 2022 Dacosta
20030191368 October 9, 2003 Wang et al.
20050288594 December 29, 2005 Lewkowicz et al.
20060004292 January 5, 2006 Beylin
20100145146 June 10, 2010 Melder
20100145419 June 10, 2010 Fraval
20100292580 November 18, 2010 Gilhuly et al.
20110275900 November 10, 2011 Gilhuly et al.
20120165627 June 28, 2012 Yamamoto
20130338479 December 19, 2013 Pogue et al.
20140180116 June 26, 2014 Lindekugel et al.
20140276102 September 18, 2014 Lee et al.
20150030542 January 29, 2015 Singhal
20150038837 February 5, 2015 Inoue et al.
20150150460 June 4, 2015 Krishnaswamy et al.
20150182196 July 2, 2015 Ninomiya et al.
20160045114 February 18, 2016 Dacosta et al.
20160206202 July 21, 2016 Frangioni
20160287211 October 6, 2016 DaCosta et al.
20170085855 March 23, 2017 Roberts et al.
20170235118 August 17, 2017 Kuster et al.
20170290515 October 12, 2017 Butte et al.
20180218508 August 2, 2018 Lee et al.
20180234603 August 16, 2018 Moore et al.
20180242848 August 30, 2018 Dacosta et al.
20180252909 September 6, 2018 Regensburger et al.
20180276814 September 27, 2018 Frangioni
20180279864 October 4, 2018 Frangioni
20180325377 November 15, 2018 Dacosta et al.
20190079011 March 14, 2019 Frangioni
20210378584 December 9, 2021 Takahashi
Foreign Patent Documents
208795 March 2022 CA
106983495 July 2017 CN
304554755 March 2018 CN
307182522 March 2022 CN
307545922 September 2022 CN
2502551 September 2012 EP
3372143 September 2018 EP
2011521237 July 2011 JP
300827516.0000 November 2015 KR
2010080611 July 2010 WO
2013184830 December 2013 WO
2016011534 January 2016 WO
2016063949 April 2016 WO
2017079844 May 2017 WO
2017082242 May 2017 WO
2017096137 June 2017 WO
2018145193 August 2018 WO
2019148268 August 2019 WO
2019213737 November 2019 WO
2020148724 July 2020 WO
2020148725 July 2020 WO
2020148726 July 2020 WO
Other references
  • BayCare, Lumicell, Inc. Selects BayCare for Pivotal Breast Cancer Trial, Published on: Oct. 9, 2020, Baycare.org, Retrieved from Internet: https://baycare.org/newsroom/2020/october/lumicell-inc-selects-baycare-for-pivotal-breast-cancer-clinical-trial (Year: 2020).
  • U.S. Appl. No. 29/842,182, filed Jun. 10, 2022.
  • Office Action dated Jun. 21, 2022 in Brazilian Patent Application No. BR 302022000890-7.
  • First Examination report dated Jun. 30, 2022 in Indian Patent Application No. 202017037681.
  • Supplementary Partial European Search report dated Sep. 20, 2022 in related EP Application No. 20740856.8, 12 pages.
  • Supplementary European Search report dated Sep. 20, 2022 in related EP Application No. 20741034.1, 27 pages.
  • Supplementary European Search report dated Sep. 26, 2022 in related EP Application No. 20741678.5, 9 pages.
  • Office Action dated Sep. 16, 2022 in related CA Application No. 3,127,036.
  • Notice of Allowance dated Sep. 27, 2022 in related JP Application No. 2022-003401.
  • Office Action dated Oct. 6, 2022 in related CA Application No. 3,127,048.
  • Office Action dated Sep. 27, 2022 in related JP Application No. 2022-019073.
  • European Search report dated Jan. 5, 2023 in related EP Application No. 20740856. 8.
  • First Examination report dated Feb. 3, 2023 in related IN App No. 202117030136.
  • U.S. Appl. No. 62/793,842, dated Jan. 17, 2019.
  • U.S. Appl. No. 62/793,846, dated Jan. 17, 2019.
  • U.S. Appl. No. 62/857,183, dated Jun. 4, 2019.
  • Design U.S. Appl. No. 29/676,901, dated Jan. 15, 2019.
  • Design U.S. Appl. No. 29/677,152, dated Jan. 17, 2019.
  • International Search Report and Written Opinion from International Patent Application No. PCT/CA2019/000015, dated Jun. 4, 2019.
  • “Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy”, 2017, Gao et al. https://www.researchgate.net/publication/315469453 Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.
  • “Current concepts and future perspectives on surgical optical imaging in cancer”,2010, Ntziachristos et al , https://vww.sniedigitallibrary.orMoumals/Jounial-of-Biomedical-Onticstvolume-15issue-61066024/Current-concepts-and-future-perspectives-on-surgical-optical-imaging-in/10.1117/1.3523364.full7SSO=I.
  • Notice of Allowance in Design U.S. Appl. No. 29/677,154, dated Apr. 1, 2020.
  • Notice of Allowance in Design U.S. Appl. No. 29/677,152, dated Apr. 1, 2020.
  • Ex Parte Quayle Action in Design U.S. Appl. No. 29/676,901, dated Mar. 5, 2020.
  • Notice of Allowance in Design U.S. Appl. No. 29/676,901, dated Jun. 4, 2020.
  • International Search Report and Written Opinion from International Patent Application No. PCT/IB2020/050384 dated Apr. 22, 2020.
  • Notice of Allowance in Design U.S. Appl. No. 29/762,417, dated Jan. 13, 2022, 13 pages.
  • Notice of Allowance in Design U.S. Appl. No. 29/767,502 dated Mar. 11, 2022, 5 pages.
  • Notice of Allowance in U.S. Appl. No. 29/767,874 dated Mar. 21, 2022.
  • International Search Report and Written Opinion from International Patent Application No. PCT/IB2020/050385 dated Apr. 8, 2020.
  • Notice of Allowance in Design U.S. Appl. No. 29/677,152, dated Sep. 22, 2020.
  • Notice of Allowance in Design U.S. Appl. No. 29/676,901, dated Sep. 18, 2020.
  • Ex Parte Quayle Action in Design U.S. Appl. No. 29/677,152, dated Dec. 20, 2019.
  • Design U.S. Appl. No. 29/762,417, dated Dec. 16, 2020.
  • Design U.S. Appl. No. 29/767,502, dated Jan. 22, 2021.
  • U.S. Appl. No. 17/423,447, dated Jul. 15, 2021.
  • U.S. Appl. No. 17/423,576, dated Jul. 16, 2021.
  • U.S. Appl. No. 17/423,609, dated Jul. 16, 2021.
  • Office Action dated Aug. 17, 2021 for U.S. Appl. No. 29/762,417, 9 pages.
  • Design U.S. Appl. No. 29/804,808, dated Aug. 23, 2021.
  • European Search Report for EP Application No. EP19746801 dated Sep. 13, 2021, 2 pages.
  • “Nagaya et al” Fluorescence-Guided Surgery, Frontiers in Oncology, vol. 7, Dec. 22, 2017, 16 pp.
  • Office Action dated Apr. 4, 2023 received in Japanese Patent Application No. 2020-541946.
  • Written Opinion dated Apr. 21, 2023 in Singapore Patent Application No. 11202107275Q.
Patent History
Patent number: D1031990
Type: Grant
Filed: Jun 14, 2022
Date of Patent: Jun 18, 2024
Assignee: SBI ALAPHARMA CANADA, INC. (Toronto)
Inventors: Ralph S. Dacosta (Toronto), Kathryn Ottolino-Perry (Toronto), Christopher Gibson (Toronto), Nayana Thalanki Anantha (Toronto), Simon Treadwell (Toronto), Connor Wright (Toronto), Kimberlyn Dampitan (Mississauga), Todd Daynes (Aurora), Todd Meaney (Thornhill)
Primary Examiner: Jennifer L Rempfer
Assistant Examiner: Edward P Jones
Application Number: 29/842,512
Classifications
Current U.S. Class: Image Generation Or Radiation Therapy (35) (D24/158)